Streamlining ENT Prior Auth with SMART on FHIR

Klivira's platform integrates seamlessly into your EMR, leveraging SMART on FHIR to automate ENT prior auth directly within the clinical workflow, eliminating manual steps and accelerating approvals.

For revenue cycle directors and prior authorization coordinators in otolaryngology practices, managing prior authorizations for high-cost procedures and biologics is a significant operational challenge. The traditional process involves extensive context-switching and manual data entry, leading to delays and potential denials. Klivira addresses this by embedding prior authorization directly into the EMR via SMART on FHIR.

The Challenge of ENT Prior Authorizations

ENT prior authorizations frequently involve complex documentation for procedures such as balloon sinuplasty, hypoglossal nerve stimulators (e.g., Inspire), and cochlear implants, as well as biologics for chronic rhinosinusitis with nasal polyps (e.g., dupilumab). Payer requirements often mandate specific imaging (CT sinus), conservative therapy trials (intranasal steroids), audiometry, or polysomnography, leading to a high administrative burden for staff.

Common ENT Procedures Requiring Prior Authorization

Sinus surgery (e.g., functional endoscopic sinus surgery / FESS, balloon sinuplasty)
Septoplasty for medical necessity (non-cosmetic)
Cochlear implants and bone-anchored hearing aids
Hypoglossal nerve stimulation (e.g., Inspire) for sleep apnea
Biologics for chronic rhinosinusitis with nasal polyps (e.g., dupilumab, mepolizumab, omalizumab)

Transforming ENT Workflows with SMART on FHIR Prior Auth

Klivira's SMART on FHIR integration enables clinicians and PA coordinators to initiate and manage prior authorizations without leaving the EMR. This eliminates the costly context-switching and manual data transfer that often plague traditional workflows. By leveraging SMART App Launch, patient and encounter context are automatically transferred, reducing transcription errors and streamlining the submission process for ENT-specific procedures and treatments.

Key Benefits of In-EMR Prior Auth for Otolaryngology

**Reduced Context-Switching:** Clinicians and staff remain within Epic, Cerner, athenahealth, or MEDITECH, improving efficiency.
**Automated Data Transfer:** FHIR R4 reads of US Core resources eliminate manual data entry for patient demographics and clinical context.
**Enhanced Documentation:** Klivira's platform supports AAO-HNS-aware policy logic, tracking conservative therapy trials and biologic step-therapy requirements.
**Structured Outcome Write-Back:** PA decisions are written back to the EMR as structured FHIR resources, ensuring consistent and queryable status updates.

Klivira's Approach to Da Vinci PAS for ENT

Our platform implements the Da Vinci PAS (Prior Authorization Support) standard, building on SMART on FHIR to provide a comprehensive prior authorization solution. This includes Da Vinci CRD (Coverage Requirements Discovery) to identify PA needs at order entry and Da Vinci DTR (Documentation Templates and Rules) to guide the collection of necessary clinical evidence, such as imaging reports or audiometry results, directly from the EMR for ENT cases.

Addressing Common ENT Prior Auth Denial Reasons

Many ENT prior auth denials stem from insufficient documentation of conservative care trials for sinus surgery, ambiguity in cosmetic-vs-medical determination for septoplasty, or non-adherence to step therapy protocols for chronic rhinosinusitis biologics. Klivira's system is designed to proactively prompt for and track these specific documentation requirements, significantly reducing the likelihood of denials and rework for high-volume ENT procedures.

Frequently asked questions

Which EMRs support Klivira's SMART on FHIR integration for ENT?

Klivira supports SMART on FHIR integration with major EMR platforms including Epic, Cerner, athenahealth, and MEDITECH. This allows ENT practices to leverage in-EMR prior authorization capabilities regardless of their core EMR system.

How does Klivira handle specific ENT documentation requirements like AAO-HNS guidelines?

Klivira's platform incorporates intelligent policy logic informed by common clinical guidelines, such as those from AAO-HNS. It guides users to provide necessary documentation like CT sinus reports, audiometry results, or records of conservative therapy trials, ensuring payer requirements are met for ENT procedures.

Can Klivira automate prior auth for biologics used in ENT?

Yes, Klivira automates prior authorization for biologics prescribed in ENT, such as dupilumab, mepolizumab, and omalizumab for chronic rhinosinusitis with nasal polyps. The system tracks and prompts for required step therapy documentation, streamlining a typically complex approval process.

What is the role of Da Vinci PAS in Klivira's ENT prior auth workflow?

Da Vinci PAS (Prior Authorization Support) is a key standard Klivira utilizes to facilitate direct submission of prior authorization requests. For ENT, this means that once all necessary clinical documentation is gathered within the SMART-launched application, the request can be submitted to payers via standardized channels, improving efficiency and reducing manual steps.

How does SMART on FHIR improve data accuracy for ENT prior authorizations?

SMART on FHIR significantly improves data accuracy by automatically pulling patient and encounter context directly from the EMR via FHIR R4. This eliminates the need for manual transcription, reducing the risk of errors in patient identification, member IDs, and clinical details for ENT prior auth submissions.